Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 1
1995 1
1999 3
2001 1
2003 3
2004 2
2005 2
2007 3
2008 2
2009 2
2010 2
2011 5
2012 11
2013 15
2014 28
2015 42
2016 42
2017 51
2018 49
2019 55
2020 43
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25035272

319 results
Results by year
Filters applied: . Clear all
Page 1
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
Bech AP, Hofstra JM, Brenchley PE, Wetzels JF. Bech AP, et al. Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17. Clin J Am Soc Nephrol. 2014. PMID: 25035272 Free PMC article.
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, Poulton K, McWilliam L, Short CD, Venning M, Brenchley PE. Kanigicherla D, et al. Kidney Int. 2013 May;83(5):940-8. doi: 10.1038/ki.2012.486. Epub 2013 Jan 30. Kidney Int. 2013. PMID: 23364522 Free article.
Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R, Hn HK, Kumar V, Nada R, Yadav AK, Goyal A, Kumar V, Rathi M, Jha V, Gupta KL, Sakhuja V, Kohli HS. Ramachandran R, et al. Nephrology (Carlton). 2016 Feb;21(2):139-46. doi: 10.1111/nep.12569. Nephrology (Carlton). 2016. PMID: 26205759 Clinical Trial.
Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.
Thokhonelidze I, Maglakelidze N, Sarishvili N, Kasradze T, Dalakishvili K. Thokhonelidze I, et al. Georgian Med News. 2015 Apr;(241):49-53. Georgian Med News. 2015. PMID: 25953939
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.
Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pellé T, Gaspari F, Suardi F, Gagliardini E, Orisio S, Benigni A, Ronco P, Remuzzi G. Ruggenenti P, et al. J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24. J Am Soc Nephrol. 2015. PMID: 25804280 Free PMC article.
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V. Kumar V, et al. Nephrology (Carlton). 2015 Aug;20(8):572-5. doi: 10.1111/nep.12478. Nephrology (Carlton). 2015. PMID: 26194981
Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
Guo N, Cao Y, Dai H, Yuan L, Shi L, Zhang Y. Guo N, et al. Med Sci Monit. 2019 Dec 9;25:9364-9368. doi: 10.12659/MSM.917732. Med Sci Monit. 2019. PMID: 31813930 Free PMC article.
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA. Radice A, et al. Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Autoimmun Rev. 2016. PMID: 26527329 Review.
The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
Chi JN, Lai TS, Wu CF, Fu TY, Chou YH, Chiu YL, Lin WC, Chiang WC, Chen YM, Wu MS. Chi JN, et al. J Formos Med Assoc. 2019 May;118(5):898-906. doi: 10.1016/j.jfma.2018.12.026. Epub 2019 Jan 11. J Formos Med Assoc. 2019. PMID: 30639075 Free article.
PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. Hoxha E, et al. PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681. eCollection 2014. PLoS One. 2014. PMID: 25313791 Free PMC article.
319 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback